Enter your terms above and click the 'Search' button.

Showing articles 0 to 3 of 3 Filter Applied: cerebral edema,vasogenic (Click to remove) Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021 Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease NEJM 392:268-276, Case 2-2025, 2025 Alzheimers Disease Lancet 397:1577-1590, Scheltens, P.,et al, 2021 Showing articles 0 to 3 of 3